# MRI-guided Holmium-166 Radioembolization

> **NCT05609448** · NA · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Primary Liver Cancer
- Non-Resectable Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** MRI-guided radioembolization

## Key facts

- **NCT ID:** NCT05609448
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-23
- **Primary completion:** 2025-01
- **Final completion:** 2025-10
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05609448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05609448, "MRI-guided Holmium-166 Radioembolization". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05609448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*